Concepedia

Publication | Open Access

A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer

DOIFull Paper Access

79

Citations

31

References

2015

Year

Eveline M. Dijkgraaf, Saskia J. Santegoets, A.K.L. Reyners, Renske Goedemans, Hans W. Nijman, Mariëtte I.E. van Poelgeest, Arien R. van Erkel, Vincent T.H.B.M. Smit, Toos Daemen, Jacobus J. M. van der Hoeven,
Oncotarget

Abstract

Combination of gemcitabine, the immune modulator Pegintron and therapeutic peptide vaccination is a viable approach in the development of combined chemo-immunotherapeutic regimens to treat cancer.

References

YearCitations

Page 1